FDA approves new treatment for advanced pancreatic cancer

FDA Approves New Treatment for Advanced Pancreatic Cancer

The U.S. Food and Drug Administration today approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients with advanced (metastatic) pancreatic cancer who have been previously treated with germcitabine-based chemotherapy...

Read more

Visit the Office of Minority Health website or follow us @FDAOMH